City

Duarte (1)

Incheon (1)

Condition

Recurrent Anaplastic Astrocytoma (3)

Recurrent Anaplastic Oligodendroglioma (3)

Recurrent Glioblastoma (3)

Recurrent Anaplastic Oligoastrocytoma (2)

Recurrent Gliosarcoma (2)

Recurrent Malignant Glioma (2)

Recurrent WHO Grade III Glioma (2)

Recurrent High-grade Glioma (1)

Recurrent WHO Grade II Glioma (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Withdrawn (1)

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

City of Hope Medical Center (2)

Dawonmedax Co., Ltd. (1)

Collaborator

National Cancer Institute (NCI) (2)

Study Documents

Intervention Type

biological (2)

drug (1)

other (1)

procedure (1)

radiation (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

recurrent anaplastic oligodendroglioma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by

Recruiting

Recurrent High-grade Glioma
+3 more

500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
+2 more

Incheon, Korea, Republic of

Gachon University Gil Medical Center

Feb 19, 2023

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Withdrawn

Recurrent Anaplastic Astrocytoma
+7 more

Neural Stem Cells-expressing CRAd-S-pk7
Resection

(no location specified)

Nov 22, 2022

Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

Active, not recruiting

Recurrent Anaplastic Astrocytoma
+6 more

Carboxylesterase-expressing Allogeneic Neural Stem Cells
+4 more

Duarte, California

City of Hope Medical Center

Jun 7, 2022